Cargando…

Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review

Background: Borneol is a terpene and bicyclic organic compound that can be extracted from plants or chemically synthesized. As an important component of proprietary Chinese medicine for the treatment of stroke, its neuroprotective effects have been confirmed in many experiments. Unfortunately, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong, Ren, Mihong, Wang, Jiajun, Ma, Rong, Chen, Hai, Xie, Qian, Li, Hongyan, Li, Jinxiu, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129537/
https://www.ncbi.nlm.nih.gov/pubmed/34017247
http://dx.doi.org/10.3389/fphar.2021.606682
_version_ 1783694312844820480
author Li, Yong
Ren, Mihong
Wang, Jiajun
Ma, Rong
Chen, Hai
Xie, Qian
Li, Hongyan
Li, Jinxiu
Wang, Jian
author_facet Li, Yong
Ren, Mihong
Wang, Jiajun
Ma, Rong
Chen, Hai
Xie, Qian
Li, Hongyan
Li, Jinxiu
Wang, Jian
author_sort Li, Yong
collection PubMed
description Background: Borneol is a terpene and bicyclic organic compound that can be extracted from plants or chemically synthesized. As an important component of proprietary Chinese medicine for the treatment of stroke, its neuroprotective effects have been confirmed in many experiments. Unfortunately, there is no systematic review of these studies. This study aimed to systematically examine the neuroprotective effects of borneol in the cascade reaction of experimental ischemic stroke at different periods. Methods: Articles on animal experiments and cell-based research on the actions of borneol against ischemic stroke in the past 20°years were collected from Google Scholar, Web of Science, PubMed, ScienceDirect, China National Knowledge Infrastructure (CNKI), and other biomedical databases. Meta-analysis was performed on key indicators in vivo experiments. After sorting the articles, we focused on the neuroprotective effects and mechanism of action of borneol at different stages of cerebral ischemia. Results: Borneol is effective in the prevention and treatment of nerve injury in ischemic stroke. Its mechanisms of action include improvement of cerebral blood flow, inhibition of neuronal excitotoxicity, blocking of Ca(2+) overload, and resistance to reactive oxygen species injury in the acute ischemic stage. In the subacute ischemic stage, borneol may antagonize blood-brain barrier injury, intervene in inflammatory reactions, and prevent neuron excessive death. In the late stage, borneol promotes neurogenesis and angiogenesis in the treatment of ischemic stroke. Conclusion: Borneol prevents neuronal injury after cerebral ischemia via multiple action mechanisms, and it can mobilize endogenous nutritional factors to hasten repair and regeneration of brain tissue. Because the neuroprotective effects of borneol are mediated by various therapeutic factors, deficiency caused by a single-target drug is avoided. Besides, borneol promotes other drugs to pass through the blood-brain barrier to exert synergistic therapeutic effects.
format Online
Article
Text
id pubmed-8129537
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81295372021-05-19 Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review Li, Yong Ren, Mihong Wang, Jiajun Ma, Rong Chen, Hai Xie, Qian Li, Hongyan Li, Jinxiu Wang, Jian Front Pharmacol Pharmacology Background: Borneol is a terpene and bicyclic organic compound that can be extracted from plants or chemically synthesized. As an important component of proprietary Chinese medicine for the treatment of stroke, its neuroprotective effects have been confirmed in many experiments. Unfortunately, there is no systematic review of these studies. This study aimed to systematically examine the neuroprotective effects of borneol in the cascade reaction of experimental ischemic stroke at different periods. Methods: Articles on animal experiments and cell-based research on the actions of borneol against ischemic stroke in the past 20°years were collected from Google Scholar, Web of Science, PubMed, ScienceDirect, China National Knowledge Infrastructure (CNKI), and other biomedical databases. Meta-analysis was performed on key indicators in vivo experiments. After sorting the articles, we focused on the neuroprotective effects and mechanism of action of borneol at different stages of cerebral ischemia. Results: Borneol is effective in the prevention and treatment of nerve injury in ischemic stroke. Its mechanisms of action include improvement of cerebral blood flow, inhibition of neuronal excitotoxicity, blocking of Ca(2+) overload, and resistance to reactive oxygen species injury in the acute ischemic stage. In the subacute ischemic stage, borneol may antagonize blood-brain barrier injury, intervene in inflammatory reactions, and prevent neuron excessive death. In the late stage, borneol promotes neurogenesis and angiogenesis in the treatment of ischemic stroke. Conclusion: Borneol prevents neuronal injury after cerebral ischemia via multiple action mechanisms, and it can mobilize endogenous nutritional factors to hasten repair and regeneration of brain tissue. Because the neuroprotective effects of borneol are mediated by various therapeutic factors, deficiency caused by a single-target drug is avoided. Besides, borneol promotes other drugs to pass through the blood-brain barrier to exert synergistic therapeutic effects. Frontiers Media S.A. 2021-05-04 /pmc/articles/PMC8129537/ /pubmed/34017247 http://dx.doi.org/10.3389/fphar.2021.606682 Text en Copyright © 2021 Li, Ren, Wang, Ma, Chen, Xie, Li, Li and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Li, Yong
Ren, Mihong
Wang, Jiajun
Ma, Rong
Chen, Hai
Xie, Qian
Li, Hongyan
Li, Jinxiu
Wang, Jian
Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review
title Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review
title_full Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review
title_fullStr Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review
title_full_unstemmed Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review
title_short Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review
title_sort progress in borneol intervention for ischemic stroke: a systematic review
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129537/
https://www.ncbi.nlm.nih.gov/pubmed/34017247
http://dx.doi.org/10.3389/fphar.2021.606682
work_keys_str_mv AT liyong progressinborneolinterventionforischemicstrokeasystematicreview
AT renmihong progressinborneolinterventionforischemicstrokeasystematicreview
AT wangjiajun progressinborneolinterventionforischemicstrokeasystematicreview
AT marong progressinborneolinterventionforischemicstrokeasystematicreview
AT chenhai progressinborneolinterventionforischemicstrokeasystematicreview
AT xieqian progressinborneolinterventionforischemicstrokeasystematicreview
AT lihongyan progressinborneolinterventionforischemicstrokeasystematicreview
AT lijinxiu progressinborneolinterventionforischemicstrokeasystematicreview
AT wangjian progressinborneolinterventionforischemicstrokeasystematicreview